Control of salivary secretions in esophageal atresia with laryngeal cleft using Botulinum toxin Type A

International Journal of Pediatric Otorhinolaryngology

Volumn 72, Issue 7, 2008, Pages 965-969

  Thevasagayam, M S ^a   Gan, Kenton ^b   Eksteen, Eduard ^c  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

^c STOLLERY CHILDREN S HOSPITAL   (Canada)

Author keywords

Aspiration; Botulinum toxin; Esophageal atresia; Larynx; Pneumonia

Indexed keywords

BOTULINUM TOXIN A; GLYCOPYRRONIUM BROMIDE;

ABSENCE OF SIDE EFFECTS; ARTICLE; ASPIRATION; ASPIRATION PNEUMONIA; CASE REPORT; CLEFT LARYNX; COMORBIDITY; ECHOGRAPHY; ELECTIVE SURGERY; ESOPHAGUS ANASTOMOSIS; ESOPHAGUS ATRESIA; FEMALE; HUMAN; INTUBATION; LARYNGOSCOPY; NEWBORN; OXYGEN THERAPY; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RESPIRATORY TRACT MALFORMATION; SALIVARY GLAND; SALIVATION; TACHYPNEA; TRACHEOSTOMY; TREATMENT RESPONSE;

BOTULINUM TOXIN TYPE A; ESOPHAGEAL ATRESIA; FEMALE; HUMANS; INFANT, NEWBORN; INJECTIONS; LARYNX; PNEUMONIA, ASPIRATION; SALIVARY GLANDS; SALIVATION;

EID: 44649121424     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2008.03.012     Document Type: Article

References (25)

1. Benjamin B., and Inglis A. Minor congenital laryngeal clefts: diagnosis and classification. Ann. Otol. Rhinol. Laryngol. 98 (1989) 417-420
2. Roth B., Rose K.G., Benz-Bohm G., and Gunther H. Laryngo-tracheo-oesophageal cleft. Clinical features, diagnosis and therapy. Eur. J. Pediatr. 140 (1983) 41-46
3. DuBois J.J., Pokorny W.J., Harberg F.J., and Smith R.J. Current management of laryngeal and laryngotracheoesophageal clefts. J. Pediatr. Surg. 25 (1990) 855-860
4. Chien W., Ashland J., Haver K., Hardy S.C., Curren P., and Hartnick C.J. Type 1 laryngeal cleft: establishing a functional diagnostic and management algorithm. Int. J. Pediatr. Otorhinolaryngol. 70 (2006) 2073-2079
5. Myer III C.M., Cotton R.T., Holmes D.K., and Jackson R.K. Laryngeal and laryngotracheoesophageal clefts: role of early surgical repair. Ann. Otol. Rhinol. Laryngol. 99 (1990) 98-104
6. Kawaguchi A.L., Donahoe P.K., and Ryan D.P. Management and long-term follow-up of patients with types III and IV laryngotracheoesophageal clefts. J. Pediatr. Surg. 40 (2005) 158-164 discussion 164-165
7. Bergman K.S., and Hoffman M.A. Laryngotracheal separation and diversion for complicated esophageal atresia with intractable salivary aspiration. J. Pediatr. Surg. 26 (1991) 1301-1302
8. Kubba H., Gibson D., Bailey M., and Hartley B. Techniques and outcomes of laryngeal cleft repair: An update to the great Ormond street hospital series. Ann. Otol. Rhinol. Laryngol. 114 (2005) 309-313
9. Nooh N., and Graves D.T. Healing is delayed in oral compared to dermal excisional wounds. J. Periodontol. 74 (2003) 242-246
10. Jongerius P.H., Rotteveel J.J., van Limbeek J., Gabreels F.J., van Hulst K., and van den Hoogen F.J. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology 63 (2004) 1371-1375
11. Mier R.J., Bachrach S.J., Lakin R.C., Barker T., Childs J., and Moran M. Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch. Pediatr. Adolesc. Med. 154 (2000) 1214-1218
12. Annis P., Landa J., and Lichtiger M. Effects of atropine on velocity of tracheal mucus in anesthetized patients. Anesthesiology 44 (1976) 74-77
13. Jongerius P.H., van den Hoogen F.J., van Limbeek J., Gabreels F.J., van Hulst K., and Rotteveel J.J. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics 114 (2004) 620-627
14. Thant Z.S., and Tan E.K. Emerging therapeutic applications of botulinum toxin. Med. Sci. Monit. 9 (2003) RA40-RA48
15. Savarese R., Diamond M., Elovic E., and Millis S.R. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am. J. Phys. Med. Rehabil. 83 (2004) 304-311 quiz 312-314, 336
16. Suskind D.L., and Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 112 (2002) 73-81
17. Vaile L., and Finlay F. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?. Arch. Dis. Child 91 (2006) 862-863
18. Jongerius P.H., van Limbeek J., and Rotteveel J.J. Assessment of salivary flow rate: biologic variation and measure error. Laryngoscope 114 (2004) 1801-1804
19. Dogu O., Apaydin D., Sevim S., Talas D.U., and Aral M. Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Clin. Neurol. Neurosurg. 106 (2004) 93-96
20. Friedman A., and Potulska A. Botulinum toxin for treatment of parkinsonian sialorrhea. Neurol. Neurochir. Pol. 35 Suppl. 3 (2001) 23-27
21. Hassin-Baer S., Scheuer E., Buchman A.S., Jacobson I., and Ben-Zeev B. Botulinum toxin injections for children with excessive drooling. J. Child Neurol. 20 (2005) 120-123
22. Jongerius P.H., Joosten F., Hoogen F.J., Gabreels F.J., and Rotteveel J.J. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands. Laryngoscope 113 (2003) 107-111
23. Gerlinger I., Szalai G., Hollody K., and Nemeth A. Ultrasound-guided, intraglandular injection of botulinum toxin A in children suffering from excessive salivation. J. Laryngol. Otol. (2007) 1-5
24. Tan E.K., Lo Y.L., Seah A., and Auchus A.P. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. J. Neurol. Sci. 190 (2001) 95-97
25. Benson J., and Daugherty K.K. Botulinum toxin A in the treatment of sialorrhea. Ann. Pharmacother. 41 (2007) 79-85